中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Probiotics for Prevention of Antibiotic-associated Diarrhea

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
University of Saskatchewan
合作者
Jarrow Formulas Inc
Institut Rosell

关键词

抽象

The purpose of this study is to evaluate if ingestion of a probiotic formula (Jarrow-Dophilus EPS)reduces incidence of diarrhea and improves the quality of life of patients receiving antibiotic therapy.

描述

A common complication of antibiotic use is antibiotic-induced diarrhea (AAD). AAD is the result of disrupted microflora, occurring two to eight weeks after antibiotic use. Probiotic supplementation may rebalance the intestinal flora, thus reducing the incidence of diarrhea, improving quality of life and reducing symptoms associated with antibiotic administration.

The proposed study will be a prospective, randomized, double blind, placebo-controlled trial that will assess the efficacy of the Jarro-Dophilus EPS probiotics formula for the prevention of AAD.

In addition,a subgroup of participants will be requested to provide one fecal sample at the initiation of the study and one sample in the last three days of probiotic (or placebo) treatment. The samples will undergo microbial analysis for routine C & S(Salmonella, Shigella, Campylobacter, Ecoli 0157, Yersinia), VRE, Yeast, Fungus culture (moulds) and C. difficile toxin.

日期

最后验证: 12/31/2009
首次提交: 03/17/2008
提交的预估入学人数: 03/20/2008
首次发布: 03/23/2008
上次提交的更新: 01/13/2010
最近更新发布: 01/14/2010
实际学习开始日期: 02/29/2008
预计主要完成日期: 08/31/2009
预计完成日期: 08/31/2009

状况或疾病

Antibiotic-Associated Diarrhea

干预/治疗

Other: Jarro-Dophilus EPS probiotics

-

手臂组

干预/治疗
Active Comparator: 1
Jarrow-Dophilus EPS
Placebo Comparator: 2
Placebo

资格标准

有资格学习的年龄 18 Years 至 18 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- 18-75 years of age

- Prescribed oral or IV antibiotics by physicians in Saskatoon Health Region's community medical clinics

Exclusion Criteria:

- Treatment with an antibiotic two weeks prior to study entry

- Underlying long term gastrointestinal disease (i.e., Ulcerative Colitis, Crohn's Disease, irritable bowel syndrome, ileostomy, colostomy)

- Pregnant or lactating

- Immunocompromised state

- Chronic illness such as Hepatitis B, Hepatitis C, renal failure

- Inability to provide informed consent, inability to speak or write in English

- Receiving tube feeds

- Insufficiently functional (physically and cognitively) to complete the study diary and questionnaires.

结果

主要结果指标

1. Incidence of patients experiencing diarrhea [Duration of antibiotic course plus 3 weeks]

次要成果指标

1. Duration of diarrhea [Duration of antibiotic course plus 3 weeks]

2. Quality of life. [Duration of antibiotic course plus 3 weeks]

3. Gastrointestinal Symptom Rating Scale score. [Duration of antibiotic course plus 3 weeks]

4. Incidence of adverse effects. [Duration of antibiotic course plus 3 weeks]

5. Presence of pathogens in fecal samples. [Duration of antibiotic course]

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge